keyword
necrot
enterocol
microbiom
intestin
microbiota
noncultur
base
techniqu
sequenc
intestin
microbiota
normal
exist
commens
symbiot
relationship
host
neonat
especi
prematur
infant
relationship
need
develop
alter
intestin
microbiota
may
predispos
preterm
infant
develop
necrot
enterocol
composit
qualiti
intestin
microbiota
depend
mani
factor
mode
birth
type
feed
use
antibiot
mani
opportun
physician
provid
intervent
could
improv
adequ
colon
neonat
gut
culturebas
techniqu
highli
limit
develop
new
molecular
technolog
studi
previous
unidentifi
organ
enhanc
understand
microbi
environ
may
predispos
necrot
enterocol
necrot
enterocol
nec
enigmat
diseas
recogn
centuri
advent
neonat
intens
care
becom
one
common
devast
diseas
neonat
among
reason
nec
difficult
understand
erad
term
nec
certainli
diseas
multipl
caus
exampl
infant
born
term
hypoplast
left
ventricl
present
pneumatosi
intestinali
day
age
caus
pathophysiolog
babi
nec
like
differ
gestat
preterm
present
pneumatosi
intestinali
week
age
first
like
relat
ischem
injuri
caus
hemodynam
insuffici
hypoxicischem
injuri
rather
coalesc
factor
result
intestin
inflamm
injuri
larg
result
intestin
immatur
preterm
infant
latter
case
sometim
refer
classic
nec
interact
predispos
genet
background
immatur
intestin
barrier
microbi
environ
conduc
develop
nec
believ
play
interact
critic
role
pathogenesi
linkag
nec
bacteri
colon
recogn
santulli
colleagu
decad
ago
addit
observ
show
cluster
case
outbreak
institut
find
pneumatosi
intestinali
like
repres
submucos
ga
produc
bacteri
ferment
common
find
bacteremia
endotoxinemia
affect
neonat
support
microbi
role
pathogenesi
diseas
numer
bacteria
relat
nec
none
found
fulfil
koch
postul
commonli
found
among
patient
without
nec
virus
also
implic
pathogenesi
nec
coronaviru
within
fecal
sampl
resect
intestin
segment
report
patient
nec
role
causat
diseas
substanti
recent
human
microbiom
project
enabl
develop
novel
technolog
highli
instrument
help
understand
contribut
intestin
microbi
ecolog
pathogenesi
nec
realiz
culturebas
techniqu
limit
delin
vast
array
microb
present
human
intestin
along
develop
new
technolog
studi
previous
unidentifi
organ
enhanc
optim
better
describ
microbi
environ
may
predispos
classic
nec
furthermor
appreci
role
commens
microb
protect
intestin
diseas
may
occur
balanc
commens
disrupt
open
new
era
thought
understand
nec
well
diseas
rang
obes
autism
effort
nation
institut
child
health
human
develop
also
pave
way
new
studi
nec
review
focus
role
intestin
microbiota
pathogenesi
classic
nec
tradit
view
human
compos
trillion
cell
product
approxim
gene
howev
variou
nich
human
bodi
resid
sever
speci
microb
microbi
gene
vastli
outnumb
human
host
past
year
emerg
technolog
deriv
larg
human
genom
project
appli
evalu
intestin
microbiota
new
discoveri
use
techniqu
prompt
new
initi
human
microbiom
roadmap
design
evalu
role
intestin
microbiom
health
diseas
begin
last
decad
culturebas
techniqu
mainstay
evalu
intestin
microb
howev
bacteri
cell
seen
microscop
fece
cultur
laboratori
fig
recent
develop
highthroughput
molecular
techniqu
analyz
microbi
dna
rna
gener
approach
compris
sever
variant
one
commonli
use
gener
approach
use
rrna
gene
complex
metagenom
approach
commun
dna
subject
shotgun
wholegenom
sequenc
comprehens
review
techniqu
beyond
scope
articl
commonli
use
techniqu
summar
box
method
includ
extract
commun
dna
rna
fece
sampl
interest
rrna
part
ribosom
rna
commonli
use
phylogenet
studi
region
gene
encod
highli
conserv
act
primer
bind
site
wherea
region
contain
phylogenet
inform
highli
variabl
enabl
use
taxonom
classif
use
approach
polymeras
chain
reaction
pcr
amplicon
sequenc
use
novel
highthroughput
pyrosequenc
technolog
base
degre
nucleotid
similar
usual
sequenc
bin
oper
taxonom
unit
form
basi
comparison
microbiota
composit
divers
sampl
although
initi
effort
taxonom
evalu
microbiom
involv
use
rrna
recent
work
focus
sequenc
genom
entir
commun
use
shotgun
techniqu
sequenc
entir
genom
use
approach
venter
colleagu
identifi
vast
number
microb
previous
recogn
exist
ocean
past
year
similar
techniqu
appli
human
intestin
microbiom
futur
refin
technolog
bioinformat
statist
analys
decreas
cost
analys
yield
import
new
inform
microb
present
intestin
relat
health
diseas
even
taxonomi
particular
microbi
commun
identifi
function
express
relat
physiolog
interact
host
clarifi
simpl
identif
individu
microb
microbi
genotyp
often
clarifi
phenotyp
express
thu
addit
microbiom
identificationbas
technolog
import
clarifi
function
microbi
commun
interest
within
particular
nich
thu
interest
identifi
mrna
protein
express
gene
well
metabolit
result
interact
microbi
gene
product
host
addit
omic
disciplin
thu
appli
augment
studi
microbiom
box
metatranscriptom
metaproteinom
metabolom
identifi
gene
express
product
mrna
protein
metabolit
result
gene
within
complex
microbi
commun
found
fecal
sampl
sever
metatranscriptom
metaproteom
studi
describ
human
intestin
microbiota
confirm
import
bacteri
function
relat
carbohydr
metabol
colon
similar
result
seen
transcript
analysi
fecal
sampl
monozygot
obes
twin
pair
metatranscriptom
torrazza
neu
analysi
fecal
sampl
healthi
volunt
metatranscriptom
data
less
studi
small
intestin
microbiota
show
enrich
sugar
phosphotransferas
pt
carbohydr
transport
system
well
energi
central
metabol
amino
acid
convers
pathway
compar
metagenom
find
suggest
rapid
uptak
ferment
avail
simpl
sugar
small
intestin
microbiota
compar
degrad
complex
carbohydr
bacteria
colon
import
carbohydr
metabol
also
evid
enorm
amount
carbohydrateact
enzym
cazym
present
gut
microbiom
anoth
recent
studi
use
fecal
sampl
studi
adult
human
found
assign
transcript
belong
metabol
cluster
sequenc
underlin
even
end
intestin
tract
microbiota
still
activ
metaproteom
studi
protein
collect
express
within
microbi
commun
usual
use
mass
spectrometrybas
analys
detect
protein
associ
microbiota
identifi
within
given
nich
studi
usual
also
use
systemsbiolog
approach
evalu
like
function
protein
produc
microbiota
recent
studi
use
nontarget
shotgun
mass
spectrometrybas
wholecommun
proteom
metaproteom
approach
first
deep
proteom
measur
thousand
protein
human
fecal
sampl
result
metaproteom
distribut
unexpect
rel
metagenom
protein
translat
energi
product
carbohydr
metabol
compar
earlier
predict
metagenom
human
protein
includ
antimicrobi
peptid
also
identifi
provid
nontarget
glimps
host
respons
microbiota
sever
unknown
protein
repres
previous
undescrib
microbi
pathway
host
immun
respons
reveal
novel
complex
interplay
human
host
associ
microb
intestin
microbiota
involv
regul
multipl
host
metabol
pathway
give
rise
interact
hostmicrobiota
metabol
signal
immuneinflammatori
process
connect
intestin
liver
muscl
brain
interact
begin
birth
like
even
fetal
life
microbiota
shape
develop
immun
system
immun
system
turn
shape
composit
microbiota
crosstalk
microb
host
immun
system
signal
process
togeth
direct
chemic
interact
microb
host
act
multipl
organ
gut
liver
muscl
brain
fig
summar
gut
bacteria
metabolit
contribut
notabl
among
metabolit
shortchain
fatti
acid
acet
propion
butyr
cholin
bile
acid
vitamin
k
polyamin
believ
import
optim
function
gastrointestin
tract
well
entir
human
product
metabolit
microb
contribut
host
alter
gut
microbiom
necrot
enterocol
metabol
phenotyp
henc
diseas
risk
despit
put
import
metabol
function
studi
avail
pertain
nec
neonat
intestin
microbiota
normal
exist
commens
symbiot
relationship
host
neonat
especi
prematur
infant
relationship
need
develop
mani
factor
defin
delic
equilibrium
capabl
modul
immun
respons
promot
health
fig
mention
earlier
specif
pathogen
fulfil
koch
postul
caus
nec
found
whether
use
newgener
sequenc
technolog
help
search
unknown
although
preliminari
studi
offer
clue
studi
wang
colleagu
fecal
sampl
preterm
infant
nec
match
control
includ
twin
pair
obtain
patient
singlesit
level
iii
neonat
intens
care
unit
bacteri
dna
subject
termin
restrict
fragment
length
polymorph
analysi
librari
sequenc
rrna
gene
distribut
sampl
patient
nec
distinctli
cluster
separ
control
intestin
bacteri
colon
preterm
infant
notabl
low
divers
patient
nec
even
less
divers
increas
abund
gammaproteobacteria
decreas
bacteria
speci
receiv
higher
mean
number
previou
day
antibiot
result
suggest
relationship
previou
use
antibiot
patient
nec
whether
differ
cluster
sampl
obtain
time
nec
babi
receiv
antibiot
clear
anoth
studi
mai
colleagu
start
first
stool
continu
discharg
weekli
stool
specimen
collect
prospect
infant
gestat
age
complet
week
less
birth
weight
g
less
highthroughput
rrna
sequenc
use
compar
divers
microbiota
preval
specif
bacteri
signatur
nec
infant
match
control
bloom
increas
proteobacteria
decreas
firmicut
nec
case
week
less
hour
detect
signific
chang
identifi
control
sever
molecular
signatur
identifi
increas
nec
case
week
within
hour
nec
develop
one
bacteri
signatur
detect
frequent
nec
case
p
match
closest
gproteobacteria
similar
wang
studi
although
sequenc
group
wellstudi
enterobacteriacea
famili
match
sequenc
genbank
observ
suggest
abnorm
pattern
microbiota
potenti
novel
pathogen
contribut
caus
nec
thu
junctur
seem
microbiota
babi
subsequ
develop
nec
differ
import
dissect
factor
contribut
differ
may
begin
fetal
life
see
fig
recent
pcrbase
studi
estim
preval
microbi
invas
amniot
caviti
higher
detect
cultivationbas
method
studi
shown
cultivationresist
anaerob
belong
famili
fusobacteriacea
particularli
sneathia
sanguinegen
leptotrichia
spp
also
commonli
found
amniot
fluid
divers
microb
detect
pcr
amniot
fluid
includ
asyet
uncultiv
uncharacter
speci
causal
relationship
divers
microb
detect
pcr
preterm
birth
support
type
associ
eg
space
time
dose
propos
altern
koch
postul
infer
causal
molecular
find
whether
colon
affect
gastrointestin
tract
fetu
known
fact
fetu
swallow
larg
quantiti
amniot
fluid
last
trimest
pregnanc
recent
find
microbi
dna
present
meconium
suggest
fetal
intestin
expos
amniot
fluid
microb
high
sensit
fetal
intestin
inflammatori
mediat
lipopolysaccharid
lp
suggest
utero
microb
may
trigger
intestin
inflamm
utero
furthermor
specul
exposur
intestin
tract
tolllik
receptor
tlr
agonist
lp
flagellin
microbi
cpg
low
quantiti
may
also
make
intestin
toler
inflammatori
stimuli
postnat
postnat
mani
factor
influenc
intestin
bacteri
colon
well
respons
colon
studi
shown
mode
deliveri
vagin
vs
cesarean
section
type
milk
human
vs
formula
use
antibiot
influenc
intestin
flora
infant
born
via
cesarean
section
fed
formula
milk
expos
antibiot
decreas
divers
intestin
microbiota
abnorm
pattern
colon
suppress
healthi
bacteria
lactobacillu
bifidobacteria
epidemiolog
data
show
relationship
increas
rate
cesarean
section
risk
develop
subsequ
diseas
recent
review
unit
state
rate
cesarean
deliveri
increas
sinc
reach
level
trend
reflect
mani
part
world
popul
countri
world
china
approach
privat
clinic
brazil
approach
concurr
trend
increas
deliveri
cesarean
section
epidem
autoimmun
diseas
type
diabet
crohn
diseas
multipl
sclerosi
allerg
diseas
asthma
allerg
rhiniti
atop
dermat
occurr
diseas
higher
affluent
western
industri
countri
review
ref
sever
previou
studi
shown
differ
microbi
colon
cesarean
section
vagin
deliveri
recent
studi
nonculturebas
sequenc
technolog
use
examin
earli
stage
colon
bodi
microb
babi
born
vagin
colon
predominantli
lactobacillu
wherea
babi
deliv
cesarean
section
colon
mixtur
potenti
pathogen
bacteria
typic
found
skin
hospit
staphylococcu
acinetobact
suggest
babi
born
cesarean
deliveri
colon
skin
flora
lieu
tradit
vagin
type
bacterium
data
relat
chang
later
outcom
celiac
diseas
allergi
atopi
compel
relationship
cesarean
torrazza
neu
section
versu
vagin
deliveri
intestin
colon
develop
nec
found
anim
human
studi
shown
human
milk
decreas
incid
nec
benefici
factor
breast
milk
includ
immunoglobulin
cytokin
lactoferrin
lysozym
growth
factor
importantli
healthi
bacteria
promot
human
milk
oligosaccharid
hmo
hmo
contain
lactos
core
act
prebiot
stimul
growth
bifidobacterium
speci
birth
rapid
colon
intestin
flora
develop
newborn
first
aerob
facult
anaerob
bacteria
enterobacteria
enterococci
staphylococci
growth
consum
oxygen
allow
prolifer
anaerob
bacteria
bacteroid
bifidobacterium
clostridium
speci
formulaf
infant
transit
tend
occur
way
newborn
intestin
flora
differ
pattern
colon
respect
breastf
infant
predomin
gramneg
fewer
anaerob
group
phyla
breastf
infant
predomin
firmicut
mainli
lactobacillu
bacteroid
actinobacteria
bifidobacterium
compar
formulaf
infant
predomin
proteobacteria
escherichia
coli
firmicut
pathogen
characterist
clostridium
staphylococcu
studi
specul
abnorm
pattern
colon
earli
birth
delay
bloom
pathogen
bacteria
late
preterm
infant
could
potenti
explain
patient
develop
nec
sullivan
colleagu
multicent
studi
use
donor
human
milk
show
exclus
human
milkbas
diet
associ
significantli
lower
rate
nec
surgic
nec
compar
mother
milkbas
diet
also
includ
bovin
milkbas
product
reduct
nec
use
strategi
human
milk
clinic
nec
almost
surgic
nec
number
need
treat
prevent
case
nec
estim
recent
polici
statement
american
academi
pediatr
regard
breastfeed
use
human
milk
recommend
offer
donor
milk
preterm
infant
mother
milk
unavail
use
antibiot
widespread
neonat
intens
care
unit
nicu
often
use
justifi
sometim
product
fear
infect
preterm
infant
nevertheless
use
antibiot
neonat
especi
preterm
infant
unintend
sometim
devast
consequ
antibiot
exposur
may
reduc
divers
intestin
microbiota
delay
colon
benefici
bacteria
predispos
preterm
neonat
nec
previou
studi
shown
durat
antibiot
exposur
associ
increas
risk
nec
among
neonat
without
previou
sepsi
one
studi
found
overgrowth
pathogen
speci
increas
day
antimicrobi
exposur
unit
state
mother
give
birth
prematur
treat
antibiot
mani
verylowbirthweight
infant
treat
cours
broadspectrum
antibiot
ampicillin
gentamicin
studi
shown
detriment
effect
antibiot
intestin
flora
even
dose
antibiot
alter
intestin
microbiota
could
take
year
recov
one
studi
show
decreas
divers
predomin
less
desir
bacteria
highli
resist
clone
abund
specif
resist
gene
result
antibiot
exposur
recov
year
exposur
cotten
colleagu
alter
gut
microbiom
necrot
enterocol
empir
treatment
day
antibiot
associ
increas
odd
death
nec
composit
measur
nec
death
investig
conclud
prolong
initi
empir
antibiot
therapi
may
associ
increas
risk
nec
death
use
caution
extrem
caution
exert
moment
decid
start
antibiot
preterm
infant
longlast
consequ
lifethreaten
situat
could
result
indiscrimin
use
antibiot
immatur
intestin
respons
alter
intestin
microbiota
predispos
intestin
neonat
inflamm
cascad
proinflammatori
counterinflammatori
cytokin
respons
proinflammatori
cytokin
tumor
necrosi
factor
tnf
interleukin
endothelin
plateletactiv
factor
increas
patient
develop
nec
intestin
flora
neonat
import
function
metabol
nutrit
immun
system
defens
pathogen
immun
system
development
regul
therefor
preterm
babi
immun
system
still
immatur
normal
recogn
fight
harm
bacteria
react
healthi
speci
bacteria
avoid
trigger
patholog
immun
respons
commens
bacteria
must
express
key
virul
factor
exampl
lp
pentacyl
bacteroid
speci
abund
intestin
flora
breastf
healthi
infant
modif
make
lipid
commens
bacteroid
poor
agonist
tlr
convers
lipid
proteobacteria
potent
agonist
like
elicit
immun
respons
hexacyl
characterist
intestin
mucosa
mechan
recognit
bacteri
product
via
highli
special
pattern
recognit
receptor
call
tlr
recogn
specif
microbialassoci
molecular
pattern
mamp
mamp
specif
tlr
exampl
lp
act
endotoxin
gramneg
bacteria
recogn
flagellin
recogn
wherea
peptidoglycan
lipotecho
acid
gramposit
bacteria
detect
tlr
express
seem
regul
pattern
intestin
colon
therefor
abnorm
pattern
colon
trigger
inappropri
respons
mamp
activ
specif
tlr
lead
activ
nuclear
factor
k
b
nfkb
caspas
turn
activ
transcript
gene
induc
cytokin
tnfa
interferon
fig
commens
healthi
bacteria
believ
regul
intestin
inflammatori
respons
exampl
studi
shown
lactobacillu
protect
cytokinemedi
cell
injuri
bifidobacterium
bacteroid
thetaiotaomicron
streptococcu
thermophilu
exampl
bacteria
play
role
cytoprotect
enterocyt
intestin
mucosa
mani
bacteria
studi
therapeut
agent
treatment
nec
promis
result
sever
studi
includ
recent
metaanalysi
literatur
show
incid
nec
decreas
infant
treat
probiot
contain
differ
combin
benefici
bacteria
probiot
seem
help
maintain
normal
intestin
flora
neonat
therebi
decreas
incid
nec
current
evid
led
recommend
level
b
effect
recommend
base
positivecontrol
studi
neg
studi
support
primari
outcom
other
suggest
dead
microb
may
effect
live
microb
modul
excess
inflammatori
stimuli
see
fig
mani
opportun
physician
take
care
neonat
provid
intervent
improv
adequ
colon
neonat
gut
minim
deleteri
often
unavoid
effect
medic
treatment
bacteri
transloc
suggest
one
mechan
develop
nec
bacteri
transloc
restrict
invas
intestin
bacteria
also
includ
bacteri
toxin
antigen
damag
intestin
epithelia
enter
circul
result
system
inflammatori
respons
inflamm
product
nitric
oxid
alter
express
local
tight
junction
disrupt
tight
junction
zonulin
protein
occludin
lead
intestin
permeabl
bacteri
transloc
studi
shown
relationship
bacteri
transloc
nec
studi
bloodstream
infect
bsi
verylowbirthweight
infant
bsi
common
diagnosi
nec
verylowbirthweight
infant
develop
intestin
failur
compar
surgic
nec
without
intestin
failur
medic
nec
coagulaseneg
staphylococcu
klebsiella
frequent
identifi
microorgan
alter
intestin
permeabl
believ
one
mechan
bsi
causat
difficult
howev
caus
bacteri
transloc
bacteri
transloc
believ
secondari
abnorm
intestin
colon
risk
factor
bacteri
transloc
discuss
elsewher
articl
factor
associ
increas
risk
nec
probabl
secondari
bacteri
transloc
histamin
h
blocker
sometim
use
nicu
shown
increas
risk
sepsi
mening
seem
increas
gastric
ph
preterm
infant
predispos
neonat
bacteri
transloc
infect
guillet
colleagu
show
studi
infant
less
g
treat
h
blocker
like
develop
nec
studi
perform
sever
year
ago
carrion
egan
report
maintain
acid
gastric
ph
less
incid
nec
decreas
higher
gastric
enter
bacteri
coloni
count
strongli
correl
gastric
ph
level
